Inhibitory action of cilostazol, a phosphodiesterase III inhibitor, on catecholamine secretion from cultured bovine adrenal chromaffin cells

J Cardiovasc Pharmacol. 2003 Jan:41 Suppl 1:S29-32.

Abstract

The effect of cilostazol, a phosphodiesterase III inhibitor, on catecholamine secretion was examined using bovine adrenal chromaffin cells in culture. Catecholamine secretion evoked by acetylcholine was markedly inhibited by cilostazol. In contrast, 56 mM K+-evoked secretion was slightly inhibited by cilostazol. Cilostazol elevated the level of cyclic AMP in the cells. However, a cyclic AMP analog (dibutyryl cAMP) or an adenylate cyclase activator (forskolin) failed to inhibit secretion of catecholamine induced by acetylcholine. Cilostazol decreased the level of intracellular free Ca2+ stimulated by acetylcholine. Cilostazol thus inhibits secretion of catecholamine through its blocking action on Ca2+ movement in the adrenal chromaffin cells.

MeSH terms

  • 3',5'-Cyclic-AMP Phosphodiesterases / antagonists & inhibitors*
  • 3',5'-Cyclic-AMP Phosphodiesterases / metabolism
  • Adrenal Medulla / drug effects
  • Adrenal Medulla / enzymology
  • Adrenal Medulla / metabolism
  • Animals
  • Catecholamines / metabolism*
  • Cattle
  • Cells, Cultured
  • Chromaffin Cells / drug effects*
  • Chromaffin Cells / enzymology*
  • Chromaffin Cells / metabolism
  • Cilostazol
  • Cyclic Nucleotide Phosphodiesterases, Type 3
  • Phosphodiesterase Inhibitors / pharmacology*
  • Tetrazoles / pharmacology*

Substances

  • Catecholamines
  • Phosphodiesterase Inhibitors
  • Tetrazoles
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 3
  • Cilostazol